Ezita®

Ezita®

Therapeutic Segment: Anti-Lipidemic

Generic Name: Ezetimibe

Indication:

For:

  • As adjunctive therapy to diet for the reduction of elevated total-C, LDLC, and Apo B in patients with primary (heterozygous familial and nonfamilial) hypercholesterolemia as monotherapy or as combination
    therapy with HMG-CoA reductase inhibitors.
  • In combination with atorvastatin or simvastatin to reduce total-C and LDL-C in patients with homozygous familial hypercholesterolemia as an adjunct to diet and other non-pharmacological or lipid lowering treatments (e.g. LDL apheresis) or if such treatments are unavailable or inadequate.
  • As adjunctive therapy to diet for the reduction of elevated sitosterol and campesterol levels in patients with homozygous familial sitosterolemia.

Available as:

Tablets
  • 10MG